JP2006520783A5 - - Google Patents

Download PDF

Info

Publication number
JP2006520783A5
JP2006520783A5 JP2006507176A JP2006507176A JP2006520783A5 JP 2006520783 A5 JP2006520783 A5 JP 2006520783A5 JP 2006507176 A JP2006507176 A JP 2006507176A JP 2006507176 A JP2006507176 A JP 2006507176A JP 2006520783 A5 JP2006520783 A5 JP 2006520783A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
hydroxy
cor
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006507176A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006520783A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/007792 external-priority patent/WO2004082682A1/en
Publication of JP2006520783A publication Critical patent/JP2006520783A/ja
Publication of JP2006520783A5 publication Critical patent/JP2006520783A5/ja
Pending legal-status Critical Current

Links

JP2006507176A 2003-03-18 2004-03-15 ケモカイン受容体活性のアミノシクロブチルアミド調節物質 Pending JP2006520783A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45604703P 2003-03-18 2003-03-18
PCT/US2004/007792 WO2004082682A1 (en) 2003-03-18 2004-03-15 Amino cyclobutylamide modulators of chemokine receptor activity

Publications (2)

Publication Number Publication Date
JP2006520783A JP2006520783A (ja) 2006-09-14
JP2006520783A5 true JP2006520783A5 (enExample) 2007-04-12

Family

ID=33030083

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006507176A Pending JP2006520783A (ja) 2003-03-18 2004-03-15 ケモカイン受容体活性のアミノシクロブチルアミド調節物質

Country Status (7)

Country Link
US (1) US7553841B2 (enExample)
EP (1) EP1617841A4 (enExample)
JP (1) JP2006520783A (enExample)
CN (1) CN1787818A (enExample)
AU (1) AU2004222336B2 (enExample)
CA (1) CA2519220A1 (enExample)
WO (1) WO2004082682A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6374762B1 (en) * 1997-10-27 2002-04-23 Correct Craft, Inc. Water sport towing apparatus
JP2007518799A (ja) * 2004-01-20 2007-07-12 メルク エンド カムパニー インコーポレーテッド ケモカイン受容体活性モジュレーターとしての2,6−二置換ピペリジン
MX2007002033A (es) * 2004-08-19 2007-04-26 Vertex Pharma Moduladores de receptores muscarinicos.
US7786141B2 (en) * 2004-08-19 2010-08-31 Vertex Pharmaceuticals Incorporated Dihydrospiroindene modulators of muscarinic receptors
JP2008521825A (ja) * 2004-11-29 2008-06-26 バーテックス ファーマシューティカルズ インコーポレイテッド ムスカリン受容体のモジュレーター
US8067457B2 (en) 2005-11-01 2011-11-29 Millennium Pharmaceuticals, Inc. Compounds useful as antagonists of CCR2
WO2007053499A2 (en) 2005-11-01 2007-05-10 Millennium Pharmaceuticals, Inc. Compounds useful as antagonists of ccr2
AU2006330866A1 (en) * 2005-12-22 2007-07-05 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
RU2008137583A (ru) * 2006-02-22 2010-03-27 Вертекс Фармасьютикалз Инкорпорейшн (Us) Спиропиперидины в качестве модуляторов мускариновых рецепторов
CN101426499A (zh) 2006-02-22 2009-05-06 弗特克斯药品有限公司 毒蕈碱受体调节剂
EP2007735B1 (en) * 2006-04-20 2010-10-27 Glaxo Group Limited 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists
EP2040706A2 (en) * 2006-06-29 2009-04-01 Vertex Pharmceuticals Incorporated Modulators of muscarinic receptors
WO2008021375A2 (en) * 2006-08-15 2008-02-21 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
KR101299720B1 (ko) * 2006-08-16 2013-08-28 주식회사 엘지생명과학 3-아미노-5-플루오로-4-디알콕시펜탄산 에스테르의 새로운제조방법
AU2007284350A1 (en) 2006-08-18 2008-02-21 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
EP2091538B1 (en) * 2006-12-20 2010-03-03 Glaxo Group Limited 4-benzyl-1(2h)-phthalazinones as h1 receptor antagonists
EP2207549A1 (en) 2007-10-03 2010-07-21 Vertex Pharmceuticals Incorporated Modulators of muscarinic receptors
JP2011500537A (ja) * 2007-10-11 2011-01-06 グラクソ グループ リミテッド H1受容体アンタゴニストとしてのフタラジンおよびピリド[3,4−d]ピリダジン化合物
US8410139B2 (en) * 2009-10-07 2013-04-02 Bristol-Myers Squibb Company Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity
AU2011268375B2 (en) * 2010-06-17 2015-02-05 Janssen Pharmaceutica Nv Cyclohexyl-azetidinyl antagonists of CCR2
CN103232340A (zh) * 2013-05-02 2013-08-07 兰州沃金环保科技有限公司 3-氧代环丁烷羧酸的合成方法
CN108135168B (zh) 2015-05-21 2021-07-20 凯莫森特里克斯股份有限公司 Ccr2调节剂
AR112831A1 (es) 2017-09-25 2019-12-18 Chemocentryx Inc Terapia de combinación usando un antagonista del receptor 2 de quimiocina (ccr2) y un inhibidor de pd-1 / pd-l1
US20190269664A1 (en) 2018-01-08 2019-09-05 Chemocentryx, Inc. Methods of treating solid tumors with ccr2 antagonists
CN112105353B (zh) 2018-01-08 2024-04-19 凯莫森特里克斯股份有限公司 Ccr2拮抗剂治疗实体瘤的方法
EP4488273A1 (en) 2023-07-06 2025-01-08 Basf Se Triazole compounds for the control of invertebrate pests
WO2025008249A1 (en) 2023-07-06 2025-01-09 Basf Se Triazole compounds for the control of invertebrate pests

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001022919A2 (en) * 1999-09-30 2001-04-05 Merck & Co., Inc. Spiro[bicyclic -azacycloalkyl and -cycloalkyl] derivatives and uses thereof
US6743794B2 (en) * 1999-12-22 2004-06-01 Eli Lilly And Company Methods and compounds for inhibiting MRP1
AU8334501A (en) * 2000-08-17 2002-02-25 Merck & Co Inc Cyclopentyl modulators of chemokine receptor activity
US20060205761A1 (en) 2003-06-06 2006-09-14 Catherine Abbadie Ccr-2 antagonists for treatment of neuropathic pain

Similar Documents

Publication Publication Date Title
JP2006520783A5 (enExample)
JP2006523704A5 (enExample)
AU2006212761B2 (en) Combination therapy
KR20190080897A (ko) 치환된 피리디논 함유 트리시클릭 화합물, 및 그의 사용 방법
JP6680679B2 (ja) 1,2ナフトキノン誘導体及びその製造方法
JP2006514003A5 (enExample)
JP2006505623A5 (enExample)
JP2009524676A5 (enExample)
JP2001233792A (ja) 急性及び慢性腎不全の処置のためのプロスタグランジン(pge2)受容体4(ep4)選択的アゴニストの使用
Ochiai et al. Phosphodiesterase inhibitors. Part 5: hybrid PDE3/4 inhibitors as dual bronchorelaxant/anti-inflammatory agents for inhaled administration
CN101460476A (zh) 有机化合物
CN108697705A (zh) 组合产品
KR20030024661A (ko) 2-아실 인돌 유도체 및 항종양제로서의 이의 용도
JP2006523193A5 (enExample)
RU2005135432A (ru) Бензоксазинил*амидоциклопентил-гетероциклические модуляторы хемокиновых рецепторов
TW201636329A (zh) 作為hdac抑制劑之雙環[4,6,0]異羥肟酸
JP2021501164A (ja) インドールアミン2,3−ジオキシゲナーゼのモジュレーター
WO2006016695A1 (ja) Ep4アゴニストを含有してなる高カリウム血症の予防および/または治療剤
WO2018236913A1 (en) Calpain modulators and therapeutic uses thereof
JP2021501756A (ja) 抗菌性化合物
JP2005500276A5 (enExample)
JP2007518799A5 (enExample)
JP2005508969A5 (enExample)
JP2007519633A5 (enExample)
JP2007534755A5 (enExample)